U.S. Senate Majority Whip Dick Durbin (D-Ill.) has introduced the Dietary Supplement Listing Act of 2024, which would require companies to provide the U.S. Food and Drug Administration with information such as product names, a list of ingredients, an electronic copy of the label, allergen statements, health claims and structure/function claims. The information would be made available to the public through an electronic database. The Consumer Healthcare Products Association called for more comprehensive reforms in a statement arguing that the bill would not address the issue of tianeptine, which Durbin has previously highlighted.
